Gilead Sciences
GILD
#80
Rank
A$313.53 B
Marketcap
A$252.79
Share price
1.60%
Change (1 day)
32.26%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): A-$4.42

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is A-$4.60. In 2025 the company made an earnings per share (EPS) of A$10.17 an increase over its 2024 EPS that were of A$0.56.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$4.42-143.45%
2025A$10.171702.63%
2024A$0.56-91.65%
2023A$6.7623.98%
2022A$5.45-25.86%
2021A$7.354850%
2020A$0.15-97.64%
2019A$6.300.9%
2018A$6.2418.71%
2017A$5.26-64.88%
2016A$14.97-18.45%
2015A$18.3555.28%
2014A$11.82296.02%
2013A$2.9817.89%
2012A$2.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.92-315.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.05-122.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$8.69-288.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$45.86-1,096.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$25.80-660.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$3.50-176.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$8.74-290.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$23.27-605.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.47-132.03%๐Ÿ‡บ๐Ÿ‡ธ USA